ACTUATE THERAPEUTICS - INITIATION OF PHASE 1/2 CLINICAL TRIAL WITH DAILY ELRAGLUSIB ORAL TABLET PLANNED FOR Q1 2027

Reuters · 2d ago

Please log in to view news